RXO financials
$20.71+2.78%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 |
|---|---|---|---|---|
| Revenue | $5.74B | $4.55B | $3.93B | $4.80B |
| Gross profit | $1.13B | $985.0M | $960.0M | $1.17B |
| Gross margin | 19.7% | 21.6% | 24.4% | 24.4% |
| Operating income | -$79.0M | -$56.0M | $39.0M | $123.0M |
| Net income | -$100.0M | -$290.0M | $4.0M | $92.0M |
| Net margin | −1.7% | −6.4% | 0.1% | 1.9% |
| Diluted EPS | $-0.59 | $-2.17 | $0.03 | $0.79 |
| EBITDA | $87.0M | $64.0M | $122.0M | $306.0M |
| Operating cash flow | $51.0M | -$12.0M | $89.0M | $310.0M |
| Free cash flow | -$8.0M | -$57.0M | $25.0M | $253.0M |
| Diluted shares | 168.5M | 133.4M | 119.5M | 115.8M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $17.0M | $35.0M | $5.0M | $98.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $404.0M | $368.0M | $359.0M | $455.0M |
| Total assets | $3.28B | $3.41B | $1.82B | $2.03B |
| Total liabilities | $1.74B | $1.80B | $1.23B | $1.44B |
| Shareholders' equity | $1.54B | $1.61B | $594.0M | $587.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology